<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Composition of and indications for diphtheria, tetanus, and pertussis vaccines for infants, children, and adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Composition of and indications for diphtheria, tetanus, and pertussis vaccines for infants, children, and adolescents</h1>
<div class="graphic"><div class="figure"><div class="ttl">Composition of and indications for diphtheria, tetanus, and pertussis vaccines for infants, children, and adolescents</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="15%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Vaccine</td> <td class="subtitle1">Diphtheria toxoid<br/> (Lf units)</td> <td class="subtitle1">Tetanus toxoid<br/> (Lf units)</td> <td class="subtitle1">Pertussis antigens</td> <td class="subtitle1">Approved doses and age groups</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Vaccines for children 6 weeks through 6 years</td> </tr> <tr> <td class="indent1"><strong>DT</strong>*</td> <td class="centered">6.7</td> <td class="centered">5</td> <td>None</td> <td>All 5 doses if there is a contraindication or precaution to pertussis vaccine (6 weeks through 6 years)</td> </tr> <tr> <td class="indent1" colspan="5"><strong>DTaP</strong></td> </tr> <tr> <td class="indent2">Daptacel</td> <td class="centered">15</td> <td class="centered">5</td> <td> <p>PT (10 mcg)</p> <p>FHA (5 mcg)</p> <p>PERT (3 mcg)</p> FIM (5 mcg)</td> <td>All 5 doses (6 weeks through 6 years)</td> </tr> <tr> <td class="indent2">Infanrix</td> <td class="centered">25</td> <td class="centered">10</td> <td> <p>PT (25 mcg)</p> <p>FHA (25 mcg)</p> PERT (8 mcg)</td> <td>All 5 doses (6 weeks through 6 years)</td> </tr> <tr> <td class="indent1" colspan="5"><strong>DTaP combination vaccines</strong></td> </tr> <tr> <td class="indent2">Kinrix (DTaP + IPV)</td> <td class="centered">25</td> <td class="centered">10</td> <td> <p>PT (25 mcg)</p> <p>FHA (25 mcg)</p> PERT (8 mcg)</td> <td>Fifth dose of DTaP, fourth dose of IPV (4 through 6 years) in children who have received 4 doses of Infanrix and/or Pediarix</td> </tr> <tr> <td class="indent2">Pediarix (DTaP + IPV + HBV)</td> <td class="centered">25</td> <td class="centered">10</td> <td> <p>PT (25 mcg)</p> <p>FHA (25 mcg)</p> PERT (8 mcg)</td> <td>All 5 doses (6 weeks through 6 years)</td> </tr> <tr> <td class="indent2">Pentacel (DTaP + IPV + Hib)</td> <td class="centered">15</td> <td class="centered">5</td> <td> <p>PT (20 mcg)</p> <p>FHA (20 mcg)</p> <p>PERT (3 mcg)</p> FIM (5 mcg)</td> <td>Four-dose series (6 weeks through 4 years)</td> </tr> <tr> <td class="indent2">Vaxelis (DTaP + IPV + Hib + HBV)</td> <td class="centered">15</td> <td class="centered">5</td> <td> <p>PT (20 mcg)</p> <p>FHA (20 mcg)</p> <p>PERT (3 mcg)</p> FIM (5 mcg)</td> <td>Three-dose series (6 weeks through 4 years)</td> </tr> <tr> <td class="indent2">Quadracel (DTaP + IPV)</td> <td class="centered">15</td> <td class="centered">5</td> <td> <p>PT (20 mcg)</p> <p>FHA (20 mcg)</p> <p>PERT (3 mcg)</p> FIM (5 mcg)</td> <td>Fifth dose of DTaP, fourth dose of IPV (4 through 6 years) in children who have received 4 doses of Daptacel or Pentacel</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Vaccines for children ≥7 years, adolescents, and adults</td> </tr> <tr> <td class="indent1"><strong>Td</strong></td> <td class="centered">2</td> <td class="centered">2 to 5</td> <td>None</td> <td>Booster dose (≥7 years)</td> </tr> <tr> <td class="indent1" colspan="5"><strong>Tdap</strong></td> </tr> <tr> <td class="indent2">Adacel</td> <td class="centered">2</td> <td class="centered">5</td> <td> <p>PT (2.5 mcg)</p> <p>FHA (5 mcg)</p> <p>PERT (3 mcg)</p> FIM (5 mcg)</td> <td>Booster dose (10 through 64 years)<sup>¶</sup></td> </tr> <tr> <td class="indent2">Boostrix</td> <td class="centered">2.5</td> <td class="centered">5</td> <td> <p>PT (8 mcg)</p> <p>FHA (8 mcg)</p> PERT (2.5 mcg)</td> <td>≥10 years<sup>¶</sup></td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>Lf: limit of flocculation; DT: diphtheria and tetanus toxoids; DTaP: diphtheria toxoid, tetanus toxoid, acellular pertussis vaccine; PT: inactivated pertussis toxin (toxoid); FHA: filamentous hemagglutinin; PERT: pertactin (an outer membrane 69-kd protein); FIM: fimbrial proteins types 2 and 3; IPV: inactivated polio vaccine; HBV: hepatitis B vaccine; Hib: <em>Haemophilus influenzae</em> type b vaccine; Td: tetanus, reduced diphtheria; Tdap: tetanus, reduced diphtheria, acellular pertussis.</p>
<p>* As of early 2023, the sole manufacturer discontinued production and distribution of the DT vaccine.</p>
¶ The Advisory Committee on Immunization Practices (ACIP) recommends off-label use of Tdap vaccine for catch-up immunization of children age 7 through 9 years and permits off-label use of Tdap vaccine in a number of other clinical scenarios (eg, wound management in children age 7 through 9 years).<sup>[1,3]</sup> Refer to UpToDate content on diphtheria, tetanus, and pertussis immunization for details.</div><div class="graphic_reference">Data from:
<ol>
<li>Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). <a href="https://www.cdc.gov/mmwr/volumes/67/rr/rr6702a1.htm?s_cid=rr6702a1_x" target="_blank">MMWR Recomm Rep 2018; 67:1</a>.</li>
<li>Vaxelis (Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, Haemophilus b conjugate [meningococcal protein conjugate] and hepatitis B [recombinant] vaccine. United States Prescribing Information. Revised December, 2018. US Food &amp; Drug Administration. Available online: <a href="https://www.fda.gov/BiologicsBloodVaccines/ucm629107.htm" target="_blank">https://www.fda.gov/BiologicsBloodVaccines/ucm629107.htm</a> (Accessed on December 28, 2018).</li>
<li>Havers FP, Moro PL, Hunter P, et al. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019. <a href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6903a5.htm" target="_blank">MMWR Morb Mortal Wkly Rep 2020; 69:77</a>.</li>
</ol></div><div id="graphicVersion">Graphic 73107 Version 25.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
